[1. ARINGER M., COSTENBADER K., DAIKH D., BRINKS R., MOSCA M., RAMSEY-GOLDMAN R., et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019;78(9):1151–9.10.1136/annrheumdis-2018-21481931383717]Search in Google Scholar
[2. AL-MOGAIREN SM. Lupus protein-losing enteropathy (LUPLE): a systematic review. Rheumatol Int. 2011;31(8):995–1001.10.1007/s00296-011-1827-921344315]Search in Google Scholar
[3. TIALMA WA. Ascites, pleural effusion, and CA 125 elevation in an SLE patient, either a Tjalma syndrome or, due to the migrated Filshie clips, a pseudo-Meigs syndrome. Gynecol Oncol. 2005;97(1):288–91.10.1016/j.ygyno.2004.12.02215790480]Search in Google Scholar
[4. HOCHBERG MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.10.1002/art.17804009289324032]Search in Google Scholar
[5. PETRI M., ORBAI AM., ALARCON GS., GORDON C., MERRILL JT., FORTIN PR., et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64(8):2677–86.10.1002/art.34473340931122553077]Search in Google Scholar
[6. YOSHIDA M., MIYATA M., SAKA M., SASAJIMA T., SATO H., TAKIGUCHI J., et al. Protein-losing enteropathy exacerbated with the appearance of symptoms of systemic lupus erythematosus. Intern Med. 2001;40(5):449–53.10.2169/internalmedicine.40.44911393422]Search in Google Scholar
[7. CHUNG U., OKA M., NAKAGAWA Y., NISHISHITA T., SEKINE N., TANAKA Y., et al. A patient with protein-losing enteropathy associated with systemic lupus erythematosus. Intern Med. 1992;31(4):521–4.10.2169/internalmedicine.31.5211633362]Search in Google Scholar
[8. WERNER DE CASTRO GR., APPENZRLLER S., BERTOLO MB., COSTALLAT LT. Protein-losing enteropathy associated with systemic lupus erythematosus: response to cyclophosphamide. Rheumatol Int. 2005;25(2):135–8.10.1007/s00296-004-0483-815249982]Search in Google Scholar
[9. TANSIR G., KUMAR P., PIUS A., SUNNY SK., SONEJA M. Pseudo-pseudo Meigs’ syndrome: a rare presentation of systemic lupus erythematosus. Reumatismo. 2019;71(2):108–12.10.4081/reumatismo.2019.114031309785]Search in Google Scholar
[10. YANG Z., LIANG Y., LI C., ZHONG R. Serum CA125 elevation is independently associated with serositis in SLE patients. Clin Exp Rheumatol. 2012;30(1):93–8.]Search in Google Scholar
[11. ZEIMET AG., MARTH C., OFFNER FA., OBRIST P, UHL-STEIDL M., FEICHTINGER H. Human peritoneal mesothelial cells are more potent than ovarian cancer cells in producing tumor marker CA-125. Gynecol Oncol. 1996;62(3):384–9.10.1006/gyno.1996.02538812537]Search in Google Scholar
[12. LI T, XIE QB. A case report of pseudo-pseudo Meigs’ syndrome. Chin Med J (Engl). 2019;132(12):1497–8.10.1097/CM9.0000000000000231662932231205113]Search in Google Scholar
[13. FAVA A, PETRI M. Systemic lupus erythematosus: diagnosis and clinical management. J Autoimmun. 2019;96:1–13.10.1016/j.jaut.2018.11.001631063730448290]Search in Google Scholar
[14. Health and Labor Sciences Research Grant Subsidy for Intractable Disease Policy Research. Project, Research on autoimmune diseases, Japan college of Rheumatology. Guideline for the management of systemic lupus erythematosus 2019;2019:226-30 (in Japanese)]Search in Google Scholar
[15. FANOURIAKIS A., KOSTOPOULOU M., ALUNNO A., ARINGER M., BAJEMA I., BOLETIS JN. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis. 2019;78(6):736–45.10.1136/annrheumdis-2019-21508930926722]Search in Google Scholar
[16. HANAOKA H., IIDA H., KIYOKAWA T., TAKAKUWA Y., KAWAHATA K. Hydroxychloroquine improves the disease activity and allows the reduction of the corticosteroid dose regardless of background treatment in Japanese patients with systemic lupus erythematosus. Intern Med. 2019;58(9):1257–62.10.2169/internalmedicine.1999-18654322930626831]Search in Google Scholar
[17. MIYAGAWA I., NAKANO K., NAKAYAMADA S., IWATA S., HANAMI K., FUKUYO S. Effectiveness and safety of hydroxychloroquine therapy with or without corticosteroid in patients with systemic lupus erythematosus. Int J Rheum Dis. 2019;22(3):434–42.10.1111/1756-185X.1338730338639]Search in Google Scholar